Pavinetant

DB11692InvestigationalSmall molecule

Pavinetant has been used in trials studying the basic science and treatment of Safety and Schizophrenia.

Chemical structure of Pavinetant
Mechanism
Curator reviewed
Formula / weight
C26H25N3O3S · 459.56 g/mol (avg)
Code names
AZ-12472520 · AZ4901 · AZD-2624 · AZD-4901 · MLE-4901

Resolves to

Compound
UNII3U471ZVC5KCAS941690-55-7ChEMBLCHEMBL3545233ChEBI140478PubChem23649245
Structure
InChIKeyQYTBBBAHNIWFOD-NRFANRHFSA-NSMILESCC[C@H](NC(=O)C1=C(NS(C)(=O)=O)C(=NC2=CC=CC=C12)C1=CC=CC=C1)C1=CC=CC=C1
Targets
P29371TACR3

What you can answer from here — as of February 21, 2021

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pavinetant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In